This Government Contract opportunity from Department Of Health And Human Services was posted on May 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NULISA Proteomic Testing Services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves providing specialized proteomic testing services using the NULISA liquid biopsy platform to analyze biobanked patient samples in the context of Alzheimer’s disease research. The work focuses on conducting high-sensitivity, multiplexed proteomic analysis aimed at biomarker discovery and ensuring data harmonization to support research efforts in understanding Alzheimer’s disease. The contract is structured as a subcontract with a deadline for response set on May 27, 2026, and is managed by the National Institutes of Health under the Department of Health and Human Services. The services will be performed in Sun City (zip code 85351), and fall under the NAICS code 541380, which relates to testing laboratories. The primary objective is to utilize advanced liquid biopsy technology to identify and validate protein biomarkers that can enhance the diagnosis and monitoring of Alzheimer’s disease. This integrative approach leverages the multiplexing capacity of the NULISA platform to handle multiple protein targets simultaneously, facilitating comprehensive and robust biomarker analysis critical for advancing therapeutic research and clinical applications.
General Info
Agency
NAICS
Place of Performance
Sun City, AZ, 85351, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
